David  Pacitti net worth and biography

David Pacitti Biography and Net Worth

Director of Apollo Endosurgery
Since November 2017, Mr. Pacitti has served as a member of our Board. Since 2015, Mr. Pacitti has served as the President of Siemens Medical Solutions USA, Inc. and Head of the Americas, Siemens Healthineers where he is responsible for leading the marketing, sales, service, and support functions in North America and Latin America, across the entire Healthineers portfolio, including medical imaging, laboratory diagnostics, therapy solutions, and services. From February 2006 to October 2015, Mr. Pacitti was with Abbott Vascular, a division of Abbott Laboratories, in a variety of commercial leadership roles. He serves as a member of the Board of Directors of the Advanced Medical Technology Association (AvaMed), the University City Science Center in Philadelphia, PA, the National Electrical Manufacturers Association (NEMA), and the Siemens Foundation. He is also a member of the CEO Council for Growth at the Chamber of Commerce for Greater Philadelphia, as well as the Children’s Hospital of Philadelphia Corporate Council, the GAVS Customer Advisory Board, the Medical University of South Carolina (MUSC) President’s Advisory Council and the NextGen Advisory Board for the University of Missouri. Mr. Pacitti received a B.A. in Economics from Villanova University. We believe Mr. Pacitti’s qualifications to serve on our Board include his extensive commercial expertise and medical device leadership experience.

What is David Pacitti's net worth?

The estimated net worth of David Pacitti is at least $0.00 as of May 19th, 2021. Mr. Pacitti owns 18,142 shares of Apollo Endosurgery stock worth more than $0 as of April 18th. This net worth estimate does not reflect any other investments that Mr. Pacitti may own. Learn More about David Pacitti's net worth.

How do I contact David Pacitti?

The corporate mailing address for Mr. Pacitti and other Apollo Endosurgery executives is 1120 SOUTH CAPITAL OF TX HWY BUILDING 1 SUITE 300, AUSTIN TX, 78746. Apollo Endosurgery can also be reached via phone at (512) 279-5100 and via email at [email protected]. Learn More on David Pacitti's contact information.

Has David Pacitti been buying or selling shares of Apollo Endosurgery?

David Pacitti has not been actively trading shares of Apollo Endosurgery during the past quarter. Most recently, David Pacitti sold 18,742 shares of the business's stock in a transaction on Wednesday, May 19th. The shares were sold at an average price of $6.87, for a transaction totalling $128,757.54. Following the completion of the sale, the director now directly owns 18,142 shares of the company's stock, valued at $124,635.54. Learn More on David Pacitti's trading history.

Who are Apollo Endosurgery's active insiders?

Apollo Endosurgery's insider roster includes John Barr (Director), Jeffrey Black (CFO), Neil Gagnon (Major Shareholder), Chas Mckhann (CEO), and David Pacitti (Director). Learn More on Apollo Endosurgery's active insiders.

David Pacitti Insider Trading History at Apollo Endosurgery

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/19/2021Sell18,742$6.87$128,757.5418,142View SEC Filing Icon  
See Full Table

David Pacitti Buying and Selling Activity at Apollo Endosurgery

This chart shows David Pacitti's buying and selling at Apollo Endosurgery by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Apollo Endosurgery Company Overview

Apollo Endosurgery logo
Apollo Endosurgery, Inc. is a medical technology company, which focuses on the design, development, and commercialization of medical devices to advance gastrointestinal therapeutic endoscopy. It offers Endoscopy, Surgical and Other products. The firm's endoscopy product portfolio consists of the OverStitch Endoscopic Suturing System, the OverStitch Sx Endoscopic Suturing System, and the Orbera Intragastric Balloon System. Its products are used by gastroenterologists and bariatric surgeons in a variety of settings to treat multiple gastrointestinal conditions including closure of acute perforations and chronic fistulas, inadvertent perforation of the GI tract, tissue closure after the removal of abnormal lesions in the esophagus, stomach or colon, the treatment of swallowing disorders, esophageal stent fixation, and obesity. The company was founded by Christopher J. Gostout and Dennis L. McWilliams in 2005 and is headquartered in Austin, TX.
Read More

Today's Range

Now: N/A

50 Day Range

MA: $9.94
Low: $9.87
High: $10.00

2 Week Range

Now: N/A

Volume

1,658,800 shs

Average Volume

1,432,125 shs

Market Capitalization

$579.72 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.31